Пресс-релиз с конгресса Общества эндокринологии ENDO 2022

В июне 2022 г. прошло ENDO 2022 — одно из ключевых международных мероприятий, посвященных эндокринным заболеваниям. В статье представлен краткий обзор клинической части мероприятия по вопросам заболеваний щитовидной железы.

1. Chou R, Dana T, Haymart M, et al. Active Surveillance Versus Thyroid Surgery for Differentiated Thyroid Cancer: A Systematic Review. Thyroid. 2022;32(4):351-367. doi: https://doi.org/10.1089/thy.2021.0539

2. Roman BR, Brito JP, Saucke MC, et al. National survey of endocrinologists and surgeons regarding active surveillance for low-risk papillary thyroid cancer. Endocr Pract. 2021;27(1):1-7. doi: https://doi.org/10.1016/j.eprac.2020.11.003

3. Tuttle RM, Fagin JA, Minkowitz G, et al. Natural History and Tumor Volume Kinetics of Papillary Thyroid Cancers During Active Surveillance. JAMA Otolaryngol Head Neck Surg. 2017;143(10):1015-1020. doi: https://doi.org/10.1001/jamaoto.2017.1442

4. Nasr CE, Andriol M, Endo M, et al. LBSAT255 Real World Performance Of The Afirma Genomic Sequencing Classifier (GSC) — A Meta-analysis. J Endocr Soc. 2022;6(1):A745–A746. doi: https://doi.org/10.1210/jendso/bvac150.1538

5. Lui D, Lee CH, Cheung C, et al. LBODP093 Evaluation Of The Impact Of Covid-19 Vaccines On Thyroid Function And Autoimmunity And The Potential Influence Of Pre-existing Thyroid Autoimmunity On Neutralizing Antibody Responses. J Endocr Soc. 2022;6(1):A738. doi: https://doi.org/10.1210/jendso/bvac150.1523

6. Chui C, Lau K, Lui D, et al. ODP514 Safety of Inactivated and mRNA COVID-19 Vaccination among Patients Treated for Hypothyroidism: a Population-based Cohort Study. J Endocr Soc. 2022;6(1):A780–A781. doi: https://doi.org/10.1210/jendso/bvac150.1614